Regenerative Approach for Chronic Pain
- Written by
- StemCell Longevita Editorial Team
- Medically reviewed by
- Prof. Dr. Erdal Karaöz TeamProfessor of Histology and Embryology · Medical Director, Center for Regenerative Medicine
- Last reviewed
- Next scheduled review
How we evaluate evidence · Conflict-of-interest disclosure · Editorial standards
Advanced mesenchymal regenerative medicine application for chronic pain conditions including fibromyalgia, neuropathic pain, and CRPS. Regenerative pain relief that targets the root cause.
Evidence at a glance — Chronic musculoskeletal pain
A plain summary of what the published research does and does not show for this condition. It is written to the same standard whether the evidence is strong or weak.
- Human studies available?
- Yes — early-stage only
- Randomised trials?
- Randomised data exist only for specific underlying diagnoses (mainly osteoarthritis)
- Main outcomes studied
- Pain intensity
- Function
- Analgesic use
- Quality of life
- Long-term evidence
- Very limited
- Regulatory approval for this indication
- United States (FDA): No FDA-approved mesenchymal stem cell product for this indication. The FDA has issued consumer warnings about unapproved stem cell products.
- European Union (EMA): No EMA-authorised mesenchymal stem cell medicine for this indication.
- United Kingdom (MHRA): No MHRA-authorised mesenchymal stem cell medicine for this indication.
- Türkiye (Ministry of Health): In Türkiye, cell therapies are delivered only inside Ministry of Health–licensed centres under the regenerative medicine / advanced therapy regulations, as clinical research or individual (exceptional) use — not as an approved routine treatment for this indication.
- Role at our centre
- Research context — considered only where standard care is exhausted or unsuitable, and never as a replacement for it
What kind of evidence exists
- Mechanism (laboratory): Documented
- Animal / preclinical: Documented
- Early human (phase 1/2, uncontrolled): Documented
- Controlled human (randomised or sham-controlled): Documented
- Regulatory approval: Not established
Sources
- Systematic reviews and meta-analyses — Chronic musculoskeletal pain — PubMed
- Randomised controlled trials — Chronic musculoskeletal pain — PubMed
- Registered MSC trials — Chronic musculoskeletal pain — ClinicalTrials.gov
- FDA — Consumer alert on regenerative medicine therapies — U.S. Food and Drug Administration, 2024
- Advanced therapy medicinal products: overview — European Medicines Agency, 2025
- ISSCR Guidelines for Stem Cell Research and Clinical Translation — International Society for Stem Cell Research, 2021
- ISSCR Patient Handbook on Stem Cell Therapies — International Society for Stem Cell Research, 2020
Source links open filtered searches of PubMed and ClinicalTrials.gov plus regulator and professional-society pages, so you can read the current evidence yourself rather than a selected extract.
This summary is general information about the evidence base, not medical advice and not a promise of benefit. Whether any treatment is appropriate for you can only be decided after a medical review of your records.
Understanding Chronic Pain and Regenerative Approach
Chronic pain affects millions of people worldwide, persisting for months or even years beyond the expected healing time. Unlike acute pain that serves as a warning signal, chronic pain involves complex changes in the nervous system, including neuroinflammation and central sensitization.
Conditions such as fibromyalgia, neuropathic pain, complex regional pain syndrome (CRPS), and chronic back pain often resist conventional treatment approaches. Patients may rely on long-term medication use that carries significant side effects without addressing the underlying cause.
Mesenchymal stem cell (MSC) therapy offers a fundamentally different approach by targeting the biological mechanisms that sustain chronic pain. MSCs release anti-inflammatory cytokines, neurotrophic factors, and immunomodulatory molecules that address pain at its source.
our approach protocols are designed for patients who have not found adequate relief through conventional pain management, offering the possibility of genuine tissue repair and long-term pain reduction.
Benefits of Regenerative Approach for Chronic Pain
Discover how regenerative medicine can help break the cycle of chronic pain and restore your quality of life.
Anti-Inflammatory Action
MSCs release potent anti-inflammatory cytokines that reduce neuroinflammation and tissue inflammation driving chronic pain.
Nerve Repair
Stem cells secrete neurotrophic factors that promote nerve regeneration and restore normal pain signaling pathways.
Immune Modulation
MSCs regulate overactive immune responses that contribute to autoimmune-driven pain conditions like fibromyalgia.
Tissue Regeneration
Stem cells promote repair of damaged cartilage, discs, and connective tissue that may be causing persistent pain.
How Stem Cells Address Chronic Pain
Chronic pain is now understood as a disease of the nervous system, not merely a symptom. Neuroinflammation, central sensitization, and glial cell activation maintain pain signals long after the original injury has healed.
Mesenchymal stem cells address these mechanisms through multiple pathways:
Neuroinflammation Reduction: MSCs release IL-10, TGF-β, and other anti-inflammatory mediators that calm activated glial cells and reduce neuroinflammatory cascades in the central nervous system.
Neurotrophic Support: Stem cells secrete brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), and glial cell-derived neurotrophic factor (GDNF) that promote nerve repair and regeneration.
Tissue Repair: MSCs differentiate into various cell types and release growth factors that regenerate damaged cartilage, intervertebral discs, and soft tissues contributing to pain.
Immune Modulation: Stem cells shift the immune system from a pro-inflammatory to an anti-inflammatory state, addressing autoimmune components of chronic pain conditions.
Pain Pathway Modulation: MSCs influence pain signaling at multiple levels, reducing central sensitization and restoring normal sensory processing in the spinal cord and brain.
The advantage of umbilical cord-derived MSCs is their high potency and immunoprivileged status, allowing for safe administration without the need for immunosuppression or donor matching.
Each treatment protocol is personalized based on the patient's specific pain condition, severity, and treatment history, ensuring optimal therapeutic outcomes.
Chronic Pain Conditions We Treat
Our regenerative pain management approach is effective for a wide range of chronic pain conditions that have not responded to conventional treatment.
Fibromyalgia
Widespread musculoskeletal pain accompanied by fatigue, sleep disturbances, and cognitive difficulties. MSCs target neuroinflammation and central sensitization.
Neuropathic Pain
Pain caused by nerve damage or dysfunction, including diabetic neuropathy and post-surgical nerve pain. Stem cells promote nerve repair and regeneration.
CRPS (Complex Regional Pain Syndrome)
Chronic pain condition typically affecting a limb after injury. MSCs modulate the dysfunctional immune and inflammatory responses driving CRPS symptoms.
Chronic Back Pain
Persistent spinal pain from degenerative disc disease, facet joint dysfunction, or soft tissue damage. Stem cells regenerate damaged structures and reduce inflammation.
Chronic Joint Pain
Persistent pain in joints from osteoarthritis, rheumatoid arthritis, or post-traumatic conditions. MSCs promote cartilage repair and reduce joint inflammation.
How Stem Cells Work for Chronic Pain
MSC therapy for chronic pain addresses the neuroinflammation, central sensitization, and tissue damage that sustain persistent pain signals long after the original injury has healed. Clinical studies suggest that MSCs can modulate pain pathways at multiple levels, repair damaged tissues, and reduce the inflammatory processes that drive chronic pain conditions.
MSCs release potent anti-inflammatory cytokines including IL-10, TGF-B, and tumor necrosis factor-stimulated gene 6 (TSG-6) that calm activated glial cells and reduce neuroinflammatory cascades in the central nervous system. This reduction in neuroinflammation addresses a fundamental mechanism that maintains chronic pain states such as fibromyalgia and neuropathic pain.
MSCs secrete neurotrophic factors including BDNF, NGF, and GDNF that promote nerve regeneration and restore normal pain signaling pathways. These factors support the repair of damaged peripheral nerves and support recovery from the central sensitization that causes the nervous system to amplify pain signals inappropriately.
For pain conditions involving tissue damage (degenerative disc disease, chronic joint pain, tendon injuries), MSCs differentiate into relevant cell types and release growth factors that regenerate damaged cartilage, intervertebral discs, and connective tissues. By repairing the structural source of pain, MSCs address chronic pain at its origin.
MSCs modulate the immune system by shifting it from a pro-inflammatory to an anti-inflammatory state, which is particularly relevant for pain conditions with autoimmune components such as fibromyalgia, complex regional pain syndrome (CRPS), and inflammatory joint conditions. This immune rebalancing can break the cycle of inflammation-driven pain.
Who Is a Good Candidate?
Candidacy for chronic pain the regenerative approach is determined through comprehensive pain assessment, including medical history review, imaging studies, pain mapping, and evaluation of previous responses. Our pain management specialists evaluate each patient to develop a targeted treatment approach.
Ideal Candidates
- Patients with chronic pain conditions such as fibromyalgia, neuropathic pain, or CRPS who have not found adequate relief through conventional pain management approaches including medications and physical therapy
- Individuals with chronic back pain from degenerative disc disease, facet joint dysfunction, or soft tissue damage who want to address the structural cause of their pain rather than relying on long-term pain medications
- Patients experiencing medication-related side effects from long-term analgesic or opioid use who seek a regenerative alternative that targets the root cause of their pain condition
- Individuals with chronic joint pain from osteoarthritis or post-traumatic conditions who have exhausted conservative treatment options but are not candidates for or prefer to avoid surgical intervention
- Patients whose chronic pain significantly impacts their quality of life, sleep, and daily function and who are motivated to pursue a comprehensive regenerative treatment approach
May Not Be Suitable
- Patients with pain from active malignancy or metastatic disease, as the pain source requires oncological management rather than regenerative treatment
- Individuals with undiagnosed pain conditions requiring further diagnostic evaluation to identify the underlying cause before regenerative treatment is appropriate
- Patients with active systemic infections, uncontrolled inflammatory conditions, or acute injuries requiring immediate medical or surgical intervention
- Individuals with severe psychological comorbidities (untreated major depression, substance use disorders) that may impair their ability to engage with the multimodal rehabilitation needed to optimize treatment outcomes
What Results Can You Expect?
Pain relief following regenerative medicine approach develops progressively as the anti-inflammatory, nerve repair, and tissue regeneration effects take hold. The timeline varies based on the specific pain condition, its severity, and duration of chronic pain.
Initial Recovery
The procedure is minimally invasive with little downtime. Some patients may experience mild soreness at injection sites. Early anti-inflammatory effects begin as MSCs start releasing therapeutic molecules into the affected tissues.
Early Improvements
Many patients report initial reductions in pain intensity, improved sleep quality, and decreased reliance on pain medications. The anti-inflammatory effects of MSCs begin to address neuroinflammation and peripheral tissue inflammation.
Progressive Results
More significant pain reduction is commonly observed as nerve repair processes progress and tissue regeneration takes effect. Patients often report improved mobility, reduced pain flares, and enhanced ability to participate in physical activities.
Optimal Results
Peak therapeutic benefits are typically achieved, with many patients experiencing substantial pain relief, restored function, and significantly improved quality of life. Tissue repair and nerve regeneration processes reach their maximum effect.
Long-Term Benefits
Sustained pain relief can persist for months to years, particularly for conditions where tissue repair addresses the structural source of pain. Periodic follow-up treatments may be recommended to maintain optimal results.
Individual results vary. These timelines are based on clinical observations and are not guaranteed outcomes. Your specialist will provide personalized expectations during your consultation.
Your Chronic Pain Care Process
Our comprehensive treatment approach is designed to provide maximum pain relief while addressing the underlying causes of your chronic pain condition.
Step 1: Pain Assessment
Comprehensive evaluation of your pain condition, including medical history, imaging studies, and pain assessment tools to develop a targeted care plan.
Step 2: Care Planning
Detailed consultation with our pain management specialists to discuss the approach approach, expected outcomes, and personalized protocol design.
Step 3: Cell Preparation
Preparation of high-potency umbilical cord-derived mesenchymal stem cells in our certified laboratory with rigorous quality testing.
Step 4: Targeted Delivery
Administration of MSCs via targeted injection or intravenous infusion, depending on the specific pain condition and care plan.
Step 5: Recovery & Follow-Up
Post-treatment monitoring, rehabilitation guidance, and follow-up consultations to track your pain reduction progress and optimize outcomes.
Pain Management Specialists
Experienced regenerative medicine team
Our multidisciplinary team combines expertise in pain management, regenerative medicine, and rehabilitation to provide comprehensive care for chronic pain patients. Each treatment protocol is tailored to your specific condition and pain history.
Patient Experiences
Real outcomes from patients who chose regenerative medicine at StemCell Longevita Istanbul
"My orthopaedic surgeon in Munich said I'd need a new knee within a year. After regenerative medicine in Istanbul, that was two years ago and I still don't need it."
"I spent years managing pain instead of living. The treatment in Turkey gave me my active life back — something I didn't think was possible at my age."
Frequently Asked Questions About Chronic Pain Treatment
Watch Our Patient Stories & Expert Insights
See real results and hear from our medical team about stem cell therapy treatments, procedures, and patient outcomes.
All Regenerative Medicine Applications
Explore our comprehensive range of regenerative medicine applications for various conditions. Click any option to learn more.
Related Articles
Explore our in-depth research articles and guides on related treatments and therapies.
Spinal Cord Injury Rehabilitation with Stem Cells
Learn about advanced regenerative medicine applications that are supporting patients with spinal cord injuries in regaining sensation and mobility through physician-directed protocols.
Read ArticleUnderstanding Regenerative Medicine: A Complete Guide
A comprehensive overview of stem cell therapy, including types of stem cells, care processes, safety considerations, and what patients can expect during their wellness journey.
Read ArticleComplete Guide to Stem Cells and Their Types
Explore the different types of stem cells - adult, fetal, embryonic, and cord blood - their unique characteristics, therapeutic applications, and how they're advancing regenerative medicine.
Read ArticleHow Much Does This Cost Worldwide?
Compare this regenerative medicine costs at StemCell Longevita versus clinics in other countries.
| Country | Typical Cost |
|---|---|
| United States | $15,000 – $25,000 |
| United Kingdom | £12,000 – £20,000 |
| Germany | €15,000 – €25,000 |
| South Korea | $12,000 – $20,000 |
| StemCell Longevita (Turkey) | From £5,900 |
Prices based on market research of comparable stem cell clinics offering umbilical cord-derived MSC treatments (2025-2026). Actual prices vary by clinic, cell count, and condition.
Related clinical questions
Where this page sits in the wider picture.